Transsphenoidal Extent of Resection Study

NCT02357498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2019-11-25

No results posted yet for this study

Summary

The purpose of this research study is to compare the extent of resection (EOR) in patients with nonfunctioning pituitary adenomas undergoing transsphenoidal surgery using a microsurgical technique to those patients who have undergone surgery with a fully endoscopic technique. Another goal is to compare surgical complications, endocrine outcomes, visual outcomes, length of surgery, length of hospital stay, and readmission rates between the two transsphenoidal surgery techniques. This is an observational data collection study with no experimental procedures or experimental medicines. Endonasal transsphenoidal removal of a pituitary tumor is a unique procedure and there is little information comparing the two surgical techniques.

Conditions

  • Pituitary Adenoma

Interventions

PROCEDURE

transsphenoidal surgery

Sponsors & Collaborators

  • Saint John's Cancer Institute

    collaborator OTHER
  • Swedish Medical Center

    collaborator OTHER
  • Northwestern University

    collaborator OTHER
  • Ohio State University

    collaborator OTHER
  • Washington University School of Medicine

    collaborator OTHER
  • University of Pittsburgh Medical Center

    collaborator OTHER
  • St. Joseph's Hospital and Medical Center, Phoenix

    lead OTHER

Principal Investigators

  • Andrew Little, MD · Saint Joseph's Hospital and Medical Center/Barrow Neurological Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2019-02-01
Completion
2019-04-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02357498 on ClinicalTrials.gov